Late AppLovin After 1,428% Run: Is It Still a Buy?
AppLovin rode a massive multi-year rally, but a pivot to pure-play ad tech and a softening macro beat have investors ...
If you need cash right now, there are several ways to obtain it quickly. Learn about options available to secure immediate funds.
24,959 articlesAppLovin rode a massive multi-year rally, but a pivot to pure-play ad tech and a softening macro beat have investors ...
A veteran hedge-fund manager behind an early SpaceX investment argues the AI-driven bottleneck trade is fading, trigg...
Older couples weighing a new life together face complex financial and legal decisions. This report outlines five esse...
A mediated settlement ends a years-long dispute between NEXA Lending's CEO and its former partner, yielding full cont...
The beautiful bill just changed how 529 plans can fund flight training, enabling tax-free use for FAA training and re...
Companies are ditching token-based performance dashboards as ROI from AI pivots to concrete business outcomes like re...
Hims & Hers Health shares have been hammered, marked by a steep decline over past year. This article breaks down the ...
A sharp uptick in Micron's revenue is grabbing attention. This article breaks down what caused the rise, whether it c...
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
Howard Marks cautions that the AI stock rally may be more speculation than solid analysis, urging investors to anchor...
Aflac has a remarkable 43-year streak of raising its dividend, a hallmark many income investors look for. But that st...
Tesla fans and skeptics alike have watched the stock struggle even as leadership paints an upbeat picture. This artic...